NYSE: HQH - Tekla Healthcare Investors

Rentabilité sur six mois: -19.27%
Rendement en dividendes: +12.68%
Secteur: Financials

Calendrier des promotions Tekla Healthcare Investors

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Tekla Healthcare Investors

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies.

plus de détails
It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 1988-01-05
ISIN US87911J1034
Industry Capital Markets
Sector Financials
Валюта usd
Валюта отчета usd
Див.доход ао 14.95
Дивиденд ао 0.57
Сайт https://www.teklacap.com/hqh.html
Цена ао 16.58
Changement de prix par jour: 0% (15.12)
Changement de prix par semaine: +6.93% (14.14)
Changement de prix par mois: -8.81% (16.58)
Changement de prix sur 3 mois: -8.81% (16.58)
Changement de prix sur six mois: -19.27% (18.73)
Changement de prix par an: -4.85% (15.89)
Evolution du prix sur 3 ans: -28.24% (21.07)
Evolution du prix sur 5 ans: +1.2% (14.94)
Evolution des prix depuis le début de l'année: -14.53% (17.69)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 90.13 1
P/BV 0.9161 9
P/E 5.25 10
EV/EBITDA 13.69 7
Total: 7.25

Efficacité

Nom Signification Grade
ROA, % 18.56 6
ROE, % 18.58 6
Total: 5.67

Dividendes

Nom Signification Grade
Div yield, % 12.68 10
DSI 0.7857 7.86
Total: 7.49

Devoir

Nom Signification Grade
Debt/EBITDA 0 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -95.57 0
Rentabilité Ebitda, % -138.77 0
Rentabilité EPS, % -34.9 0
Total: 0
Plus de détails

Plus de détails

Établissements Volume Partager, %
Morgan Stanley 3021776 6.25
Saba Capital Management, L.P. 1424346 2.95
Cornerstone Advisors, LLC 732299 1.51
AQR Arbitrage LLC 500418 1.03
Royal Bank of Canada 469916 0.97
RPO LLC 382486 0.79
Clough Capital Partners, LP 323228 0.67
BOOTHBAY FUND MANAGEMENT, LLC 312251 0.65
Logan Stone Capital, LLC 297287 0.61
Eschler Asset Management LLP 263560 0.55



Superviseur Titre d'emploi Paiement Année de naissance
Dr. Daniel R. Omstead M.S, Ph.D. Portfolio Manager N/A 1953 (72 année)
Dr. Jason C. Akus M.B.A., M.D., MBA Vice President of Research and Portfolio Manager N/A
Mr. Christopher F. Brinzey MBA Senior Vice President of Research and Portfolio Manager N/A
Dr. Frank T. Gentile Ph.D. Senior Vice President of Research and Portfolio Manager N/A 1962 (63 année)

Adresse: United States, Boston. MA, 100 Federal Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.teklacap.com/hqh.html